Loading data for BOLD — first visit, this takes a few seconds.

Preisalarm

Boundless Bio Inc. (BOLD)

NasdaqGS: BOLD · Echtzeitkurs · USD

2.86

+0.00 (0.00%)

Zum Schluss: Aug 19, 2026, 8:00 PM

2.85

-0.35%

Nachbörslich: 4:57 PM

0.00% (1D)

Keine Daten verfügbar

Geld	2.05
Marktkapitalisierung	65.06 Mio
Umsatz (TTM)	n/a
Nettogewinn (TTM)	-64.01 Mio
Beta	0.38
EPS (ttm)	-2.85
KGV (TTM)	n/a
Forward-KGV	-2.92
KBV (TTM)	0.97
KUV (TTM)	n/a
Earnings Date	n/a

Brief	2.84
Volumen	95,547
Ø Vol. (20D)	1,289,464
Eröffnung	2.89
Vortagesschluss	2.86
Tagesspanne	2.80 - 2.94
52-Wk Range	0.96 - 2.97
Analyst	n/a
Kursziel	n/a
Dividenden	n/a
Ex-Dividenden-Datum	n/a

Über BOLD

Boundless Bio, Inc., a clinical-stage oncology company, develops interrogating extrachromosomal DNA (ecDNA) directed therapies for treating patients with oncogene amplified cancers. Its lead product candidate is BBI-940, an ecDNA-directed therapeutic candidate (ecDTx) that is in Phase 1/2 clinical trial in patients with estrogen receptor positive and human epidermal growth factor receptor 2 negative breast cancer, as well as patients with triple-...

[Mehr lesen]

Branche Biotechnology

Sektor Healthcare

IPO Datum Mar 28, 2024

Mitarbeiter 28

Börse NasdaqGS

Tickersymbol BOLD

Website https://boundlessbio.com

Vollständiges Unternehmensprofil

Finanzielle Entwicklung

Im Jahr 2025 betrug der Umsatz von Boundless Bio 0, ein Anstieg von undefined% im Vergleich zum Vorjahr (0). Der Gewinn lag bei -58.2 Mio, ein Rückgang von -10.96 %.

Finanzberichte

Gewinnüberraschung

Boundless Bio hat die Quartalszahlen am Aug 7, 2026 veröffentlicht:

Umsatz von $0 verfehlt die Erwartungen um $0, mit NaN% Wachstum im Jahresvergleich.

EPS von -1.06 verfehlt die Erwartungen um -0.48, mit -51.43% Rückgang im Jahresvergleich.

Nachrichten

vor 1 Monat · Stocktwits

Why Did BOLD, BLZE, QNT Stocks Surge To 52-Week Highs Today

Investors showed interest in businesses tied to artificial intelligence infrastructure, advanced biotechnology, and quantum computing.

vor 1 Monat · MT Newswires

Sector Update: Healthcare Stocks Higher Late Afternoon

Healthcare stocks rose late Tuesday afternoon, with the NYSE Healthcare Index adding 1.5% and the St

vor 1 Monat · MT Newswires

Sector Update: Healthcare Stocks Advance in Afternoon Trading

Healthcare stocks rose Tuesday afternoon, with the NYSE Healthcare Index adding 1.4% and the State S

vor 1 Monat · Stocktwits

BOLD Stock Is Up 90% — Here's What's Behind The Biggest Rally In Company History

Boundless Bio is set to merge with Serapha Bio, with the transaction set to close in the fourth quarter of 2026.

vor 6 Monaten · Zacks

Boundless Bio, Inc. (BOLD) Upgraded to Buy: Here's Why

Boundless Bio, Inc. (BOLD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Seite 1 von 2

Boundless Bio Inc. (BOLD)